1. OP0091 A TWO-SCORE INTERFERON SIGNATURE AND MUSCULOSKELETAL IMAGING EXPLAIN THE ASSOCIATION BETWEEN INTERFERON AND ARTHRITIS IN SLE. (2nd June 2020) Authors: Wigston, Z.; Burska, A.; Alase, A.; Mahmoud, K.; Vital, E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0251 IMMUNOPHENOTYPIC CLUSTERS OF SLE PATIENTS REVEAL SUBGROUPS WITH SEVERE DISEASE RESISTANT TO CONVENTIONAL THERAPY. (2nd June 2020) Authors: Psarras, A.; Li, D.; Alase, A.; Wigston, Z.; Bruce, I.; Mchugh, N.; Vital, E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0328 Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): first results from a proof-of-concept phase 2 trial. (12th June 2018) Authors: Md Yusof, M.Y.; Wittmann, M.; Fernandez, C.; Wilson, D.; Edward, S.; Abignano, G.; Alase, A.; Sharples, L.; Laws, P.; Goodfield, M.J.; Vital, E.M.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0180 Type i interferon is produced by non-haematopoietic tissue resident cells but not pdcs in pre-clinical autoimmunity and sle. (12th June 2018) Authors: Psarras, A; Alase, A.; Antanaviciute, A.; Carr, I.; Wittmann, M.; Tsokos, G.; Emery, P.; Vital, E.M. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0680 Tetherin, a novel type i interferon biomarker on blood leucocytes can capture interferon status and correlates with ustekinumab (STELARA) therapy response in psoriatic disease. (12th June 2018) Authors: El-Sherbiny, Y. M.; Savage, L.; Alase, A.; Vital, E.; Wittmann, M.; Emery, P.; McGonagle, D. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0368 IL-22 Impact on Human Bone Marrow Mesenchymal Stem Cells Functions; A Novel Pathway That May Contribute To Aberrant New Bone Formation in Human SPA. (15th July 2016) Authors: El-Sherbiny, Y.; El-Zayadi, A.; Churchman, S.; Baboolal, T.; Cuthbert, R.; El-Jawhari, J.; Alase, A.; Badawy, A.; Jones, E.; McGonagle, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗